Nikos G. Gavalas

1.1k citations

21 papers · 772 indexed · h-index 14

Co-authors: E. Helen Kemp Anthony P. Weetman Meletios Α. Dimopoulos Philip F. Watson David J. Gawkrodger Aristotle Bamias L.N. Johnson Katerina E. Tsitsanou
Topics: melanin and skin pigmentation (5 papers)Ovarian cancer diagnosis and treatment (5 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)
Cited by: Reproductive Medicine Cell Biology Immunology
Journals: PLoS ONE The Journal of Clinical Endocrinology & Metabolism Biochemical and Biophysical Research Communications
Partner nations: Greece United Kingdom United States

In The Last Decade

Nikos G. Gavalas

19 papers receiving 755 citations

Peers

Countries citing papers authored by Nikos G. Gavalas

Since Specialization

Citations

This map shows the geographic impact of Nikos G. Gavalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikos G. Gavalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikos G. Gavalas more than expected).

Fields of papers citing papers by Nikos G. Gavalas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikos G. Gavalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikos G. Gavalas. The network helps show where Nikos G. Gavalas may publish in the future.

Co-authorship network of co-authors of Nikos G. Gavalas

This figure shows the co-authorship network connecting the top 25 collaborators of Nikos G. Gavalas. A scholar is included among the top collaborators of Nikos G. Gavalas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikos G. Gavalas. Nikos G. Gavalas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intravesical Administration of Durvalumab for High-risk Non–muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group 2025 ·European Urology ·(unknown),Aristotelis Bamias,Nikos G. Gavalas,Kimon Tzannis,(unknown),(unknown),(unknown),Γεώργιος Παπαδόπουλος,(unknown),(unknown),Penelope Korkolopoulou,(unknown),Konstantinos Stravodimos,(unknown),Dionysios Mitropoulos,Andreas Skolarikos,Athanasios Papatsoris	0
2	Optical fiber sensors in agricultural applications 2022 ·Maria Konstantaki,(unknown),(unknown),(unknown),(unknown),Nikos G. Gavalas,(unknown),(unknown),Stavros Pissadakis	3
3	Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer 2021 ·PLoS ONE ·Dimitra Stefanou,Aristotelis Bamias,(unknown),Soterios Α. Kyrtopoulos,(unknown),(unknown),(unknown),Nikos G. Gavalas,Petros P. Sfikakis,Meletios Α. Dimopoulos,Vassilis L. Souliotis	1
4	Physicochemical Properties of Magnetic Nanoparticles: Implications for Biomedical Applications In Vitro and In Vivo 2018 ·Oncology Research and Treatment ·(unknown),Nikos G. Gavalas,(unknown),(unknown),А. В. Солдатов,Peter V. Zolotukhin	37
5	The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling 2016 ·PLoS ONE ·(unknown),Eleftherios Pilalis,Nikos G. Gavalas,Kimon Tzannis,Olga Papadodima,Michalis Liontos,Alexandros Rodolakis,G. Vlachos,Nikolaos Thomakos,Dimitrios Haidopoulos,(unknown),Konstantinos Koutsoukos,(unknown),Evangelos Terpos,Aristotelis Chatziioannou,Meletios Α. Dimopoulos,Aristotelis Bamias	21
6	Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer 2015 ·PLoS ONE ·Dimitra Stefanou,Aristotelis Bamias,(unknown),Soterios Α. Kyrtopoulos,(unknown),(unknown),(unknown),Nikos G. Gavalas,Petros P. Sfikakis,Meletios Α. Dimopoulos,Vassilis L. Souliotis	31
7	Angio-Inhibitors in Ovarian Cancer 2014 ·Journal of Cancer Science & Therapy ·Nikos G. Gavalas	0
8	Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer 2013 ·International Journal of Molecular Sciences ·Nikos G. Gavalas,Michalis Liontos,(unknown),Tina Bagratuni,(unknown),Christine‐Ivy Liacos,Meletios Α. Dimopoulos,Aristotle Bamias	107
9	VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2 2011 ·International Journal of Cancer ·Apostolos C Ziogas,Nikos G. Gavalas,Marinos Tsiatas,Ourania Tsitsilonis,Ekaterini Politi,Evangelos Terpos,Alexandros Rodolakis,George Vlahos,Nikolaos Thomakos,Dimitrios Haidopoulos,A. Antsaklis,Meletios Α. Dimopoulos,Aristotle Bamias	129
10	Immune Response in Ovarian Cancer: How Is the Immune SystemInvolved in Prognosis and Therapy: Potential for Treatment Utilization 2010 ·Journal of Immunology Research ·Nikos G. Gavalas,Alexandra Karadimou,Meletios Α. Dimopoulos,Aristotelis Bamias	45
11	Mapping of melanin‐concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies 2009 ·Experimental Dermatology ·Nikos G. Gavalas,Raju V.S.R.K. Gottumukkala,David J. Gawkrodger,Philip F. Watson,Anthony P. Weetman,E. Helen Kemp	12
12	The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult 2009 ·European Journal of Endocrinology ·Marinella Tzanela,(unknown),(unknown),(unknown),Nikos G. Gavalas,(unknown),(unknown),(unknown),(unknown)	7
13	Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1 2009 ·The Journal of Clinical Endocrinology & Metabolism ·E. Helen Kemp,Nikos G. Gavalas,Kai Krohn,Edward M. Brown,Philip F. Watson,Anthony P. Weetman	43
14	Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies 2009 ·Oncology Reviews ·Nikos G. Gavalas,Meletios Α. Dimopoulos,Aristotelis Bamias	1
15	The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 2007 ·The Journal of Clinical Endocrinology & Metabolism ·Nikos G. Gavalas,E. Helen Kemp,Kai Krohn,Edward M. Brown,Philip F. Watson,Anthony P. Weetman	58
16	Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo 2006 ·Biochemical and Biophysical Research Communications ·Nikos G. Gavalas,Samia Akhtar,David J. Gawkrodger,Philip F. Watson,Anthony P. Weetman,E. Helen Kemp	59
17	Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo 2006 ·Autoimmunity Reviews ·E. Helen Kemp,Nikos G. Gavalas,David J. Gawkrodger,Anthony P. Weetman	67
18	Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients 2006 ·Laboratory Investigation ·Raju V.S.R.K. Gottumukkala,Nikos G. Gavalas,Samia Akhtar,Russell Metcalfe,David J. Gawkrodger,John W. Haycock,Philip F. Watson,Anthony P. Weetman,E. Helen Kemp	18
19	An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population 2005 ·Archives of Dermatological Research ·Samia Akhtar,Nikos G. Gavalas,David J. Gawkrodger,Philip F. Watson,Anthony P. Weetman,E. Helen Kemp	18
20	A new allosteric site in glycogen phosphorylase b as a target for drug interactions 2000 ·Structure ·Nikos G. Oikonomakos,V.T. Skamnaki,Katerina E. Tsitsanou,Nikos G. Gavalas,L.N. Johnson	100

About Nikos G. Gavalas

Nikos G. Gavalas is a scholar working on Reproductive Medicine, Immunology and Cell Biology, having authored 21 papers that have together received 772 indexed citations. Recurring topics across this work include melanin and skin pigmentation (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Reproductive Medicine (89 citations), Cell Biology (156 citations) and Immunology (199 citations). Nikos G. Gavalas has collaborated with scholars based in Greece, United Kingdom and United States. Frequent co-authors include E. Helen Kemp, Anthony P. Weetman, Meletios Α. Dimopoulos, Philip F. Watson, David J. Gawkrodger, Aristotle Bamias, L.N. Johnson, Katerina E. Tsitsanou, V.T. Skamnaki and Nikos G. Oikonomakos. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact